VENLAFAXINE- venlafaxine hydrochloride tablet
国: アメリカ合衆国
言語: 英語
ソース: NLM (National Library of Medicine)
情報リーフレット 有効成分:
VENLAFAXINE HYDROCHLORIDE (UNII: 7D7RX5A8MO) (VENLAFAXINE - UNII:GRZ5RCB1QG)
から入手可能:
Aurobindo Pharma Limited
INN（国際名）:
VENLAFAXINE HYDROCHLORIDE
構図:
VENLAFAXINE 25 mg
投与経路:
ORAL
処方タイプ:
PRESCRIPTION DRUG
適応症:
Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets, USP in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ). A major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. The ef
製品概要:
Venlafaxine Tablets USP, 25 mg are peach colored, circular, biconvex, uncoated tablets debossed with ‘I’ and breakline on one side and ‘17’ on the other side. Bottles of 30 NDC 65862-404-30 Bottles of 60 NDC 65862-404-60 Bottles of 90 NDC 65862-404-90 Bottles of 100 NDC 65862-404-01 Bottles of 1,000 NDC 65862-404-99 Bottles of 7,000 NDC 65862-404-71 10 x 10 Unit-dose Tablets NDC 65862-404-10 Venlafaxine Tablets USP, 37.5 mg are peach colored, circular, biconvex, uncoated tablets debossed with ‘I’ and breakline on one side and ‘19’ on the other side. Bottles of 30 NDC 65862-405-30 Bottles of 60 NDC 65862-405-60 Bottles of 90 NDC 65862-405-90 Bottles of 100 NDC 65862-405-01 Bottles of 1,000 NDC 65862-405-99 Bottles of 6,000 NDC 65862-405-66 10 x 10 Unit-dose Tablets NDC 65862-405-10 Venlafaxine Tablets USP , 50 mg are peach colored, circular, biconvex, uncoated tablets debossed with ‘I’ and breakline on one side and ‘20’ on the other side. Bottles of 30 NDC 65862-406-30 Bottles of 90 NDC 65862-406-90 Bottles of 100 NDC 65862-406-01 Bottles of 1,000 NDC 65862-406-99 Bottles of 5,000 NDC 65862-406-59 10 x 10 Unit-dose Tablets NDC 65862-406-10 Venlafaxine Tablets USP , 75 mg are peach colored, circular, biconvex, uncoated tablets debossed with ‘I’ and breakline on one side and ‘21’ on the other side. Bottles of 30 NDC 65862-407-30 Bottles of 90 NDC 65862-407-90 Bottles of 100 NDC 65862-407-01 Bottles of 1,000 NDC 65862-407-99 Bottles of 7,000 NDC 65862-407-71 10 x 10 Unit-dose Tablets NDC 65862-407-10 Venlafaxine Tablets USP , 100 mg are peach colored, circular, biconvex, uncoated tablets debossed with ‘I’ and breakline on one side and ‘22’ on the other side. Bottles of 20 NDC 65862-408-20 Bottles of 90 NDC 65862-408-90 Bottles of 100 NDC 65862-408-01 Bottles of 1,000 NDC 65862-408-99 Bottles of 6,000 NDC 65862-408-66 10 x 10 Unit-dose Tablets NDC 65862-408-10 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature] in a dry place. Dispense in a well-closed container as defined in the USP. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad–500 032, India Revised: 08/2023 Dispense with Medication Guide available at: www.aurobindousa.com/medication-guides.
認証ステータス:
Abbreviated New Drug Application
情報リーフレット
VENLAFAXINE - VENLAFAXINE HYDROCHLORIDE TABLET
Aurobindo Pharma Limited
----------
MEDICATION GUIDE
Venlafaxine Tablets, USP
(ven'' la fax' een hye'' droe klor' ide)
Read the Medication Guide that comes with venlafaxine tablets before
you start taking them and each time
you get a refill. There may be new information. This Medication Guide
does not take the place of talking to
your healthcare provider about your medical condition or treatment.
Talk with your healthcare provider if
there is something you do not understand or want to learn more about.
What is the most important information I should know about venlafaxine
tablets?
Venlafaxine tablets and other antidepressant medicines may cause
serious side effects, including:
1. Suicidal thoughts or actions:
•
Venlafaxine tablets and other antidepressant medicines may increase
suicidal thoughts or actions in
some children, teenagers, or young adults within the first few months
of treatment or when the dose is
changed.
•
Depression or other serious mental illnesses are the most important
causes of suicidal thoughts or
actions.
•
Watch for these changes and call your healthcare provider right away
if you notice:
•
New or sudden changes in mood, behavior, actions, thoughts, or
feelings, especially if severe.
•
Pay particular attention to such changes when venlafaxine tablets are
started or when the dose
is changed.
Keep all follow-up visits with your healthcare provider and call
between visits if you are worried about
symptoms.
Call your healthcare provider right away if you have any of the
following symptoms, or call 911 if an
emergency, especially if they are new, worse, or worry you:
•
attempts to commit suicide
•
acting on dangerous impulses
•
acting aggressive or violent
•
thoughts about suicide or dying
•
new or worse depression
•
new or worse anxiety or panic attacks
•
feeling agitated, restless, angry or irritable
•
trouble sleeping
•
an increase in activity or talking more than what is normal for you
•
other unusual changes in beh
完全なドキュメントを読む
製品の特徴
VENLAFAXINE - VENLAFAXINE HYDROCHLORIDE TABLET
AUROBINDO PHARMA LIMITED
----------
VENLAFAXINE TABLETS, USP
RX ONLY
SUICIDALITY AND ANTIDEPRESSANT DRUGS
ANTIDEPRESSANTS INCREASED THE RISK COMPARED TO PLACEBO OF SUICIDAL
THINKING AND BEHAVIOR (SUICIDALITY) IN CHILDREN, ADOLESCENTS, AND
YOUNG
ADULTS IN SHORT-TERM STUDIES OF MAJOR DEPRESSIVE DISORDER (MDD) AND
OTHER PSYCHIATRIC DISORDERS. ANYONE CONSIDERING THE USE OF VENLAFAXINE
HYDROCHLORIDE OR ANY OTHER ANTIDEPRESSANT IN A CHILD, ADOLESCENT, OR
YOUNG ADULT MUST BALANCE THIS RISK WITH THE CLINICAL NEED. SHORT-TERM
STUDIES DID NOT SHOW AN INCREASE IN THE RISK OF SUICIDALITY WITH
ANTIDEPRESSANTS COMPARED TO PLACEBO IN ADULTS BEYOND AGE 24; THERE
WAS A REDUCTION IN RISK WITH ANTIDEPRESSANTS COMPARED TO PLACEBO IN
ADULTS AGED 65 AND OLDER. DEPRESSION AND CERTAIN OTHER PSYCHIATRIC
DISORDERS ARE THEMSELVES ASSOCIATED WITH INCREASES IN THE RISK OF
SUICIDE. PATIENTS OF ALL AGES WHO ARE STARTED ON ANTIDEPRESSANT
THERAPY
SHOULD BE MONITORED APPROPRIATELY AND OBSERVED CLOSELY FOR CLINICAL
WORSENING, SUICIDALITY, OR UNUSUAL CHANGES IN BEHAVIOR. FAMILIES AND
CAREGIVERS SHOULD BE ADVISED OF THE NEED FOR CLOSE OBSERVATION AND
COMMUNICATION WITH THE PRESCRIBER. VENLAFAXINE HYDROCHLORIDE IS NOT
APPROVED FOR USE IN PEDIATRIC PATIENTS. (SEE WARNINGS: CLINICAL
WORSENING AND SUICIDE RISK, PRECAUTIONS: INFORMATION FOR PATIENTS,
AND PRECAUTIONS: PEDIATRIC USE)
DESCRIPTION
Venlafaxine hydrochloride is a structurally novel antidepressant for
oral administration. It
is designated
(R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol
hydrochloride or
(±)-1-[α-[(dimethyl-amino)methyl]-p-methoxybenzyl]cyclohexanol
hydrochloride and has the molecular formula of C
H
NO HCl. Its molecular weight is
313.87. The structural formula is shown below.
17
27
2
Venlafaxine hydrochloride USP is a white or almost white crystalline
powder with a
solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M
with sodium
chloride). Its octanol:water (0.2 M sodium chloride) partition
coeffi
完全なドキュメントを読む
